Canada Regulators Approve Meridian's C. Difficile Assay | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today announced that Health Canada has given an approved medical device license to its molecular amplification assay for Clostridium difficile.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.